Drugs / Autologous biologic drug of innovative therapy /cell therapy drug
Autologous biologic drug of innovative therapy /cell therapy drug
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04352075 | Nov 2018 → Aug 2019 | osteoarthritis, knee | Clinique Juge | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous biologic drug of innovative therapy /cell therapy drug | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04352075 ↗ |
| Route | Other | “single intra-articular injection of MF with or without PRP” PMID 33887408 ↗ Apr 2021 |